1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Irritable Bowel Syndrome Treatment Market
2.2. Global Irritable Bowel Syndrome Treatment Market, By Type, 2023 (US$ Million)
2.3. Global Irritable Bowel Syndrome Treatment Market, By Product, 2023 (US$ Million)
2.4. Global Irritable Bowel Syndrome Treatment Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Irritable Bowel Syndrome Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Irritable Bowel Syndrome Treatment Market Vendors
3.2. Strategies Adopted by Irritable Bowel Syndrome Treatment Market Vendors
3.3. Key Industry Strategies
4. Irritable Bowel Syndrome Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Irritable Bowel Syndrome Treatment Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. IBS-C
5.3.1.1. Linzess/Constella
5.3.1.2. Amitiza
5.3.1.3. Others
5.3.2. IBS-D
5.3.2.1. Xifaxan
5.3.2.2. Viberzi
5.3.2.3. Others

6. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Xifaxan
6.3.2. Linzess/Constella
6.3.3. Viberzi
6.3.4. Amitiza
6.3.5. Others


7. North America Irritable Bowel Syndrome Treatment Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
7.3. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
7.4.Irritable Bowel Syndrome Treatment Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
7.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
7.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
7.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)

8. UK and European Union Irritable Bowel Syndrome Treatment Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
8.3. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
8.4.Irritable Bowel Syndrome Treatment Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
8.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
8.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
8.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
8.4.1.4.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
8.4.1.5.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
8.4.1.6.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)

9. Asia Pacific Irritable Bowel Syndrome Treatment Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
9.3. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
9.4.Irritable Bowel Syndrome Treatment Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
9.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
9.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
9.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
9.4.1.4.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
9.4.1.5.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
9.4.1.6.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)

10. Latin America Irritable Bowel Syndrome Treatment Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
10.3. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
10.4.Irritable Bowel Syndrome Treatment Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
10.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
10.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
10.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)

11. Middle East and Africa Irritable Bowel Syndrome Treatment Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
11.3. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
11.4.Irritable Bowel Syndrome Treatment Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
11.4.1.1.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
11.4.1.2.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Irritable Bowel Syndrome Treatment Market: By Type, 2022-2032, USD (Million)
11.4.1.3.2. Irritable Bowel Syndrome Treatment Market: By Product, 2022-2032, USD (Million)

12. Company Profile
12.1. Allergan
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Takeda Pharmaceutical Company
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. AbbVie.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Takeda Pharmaceutical Company Limited
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Pfizer, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Abbott Laboratories
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Novartis AG
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. AstraZeneca PLC
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Ironwood Pharmaceuticals Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Bausch Health Companies Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. GlaxoSmithKline, Plc.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Lexicon Pharmaceuticals, Inc.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Sucampo Pharmaceuticals, Inc.
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. Other Notable Players
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives